Skip to main content
. 2021 Sep 16;11:729230. doi: 10.3389/fonc.2021.729230

Figure 10.

Figure 10

Relationship between ADAM12 expression and immune components in patients with COAD, including lymphocytes, immunomodulators, and chemokines. (A) Relationship between the ADAM12 expression level and lymphocytes. (B–D) Relationship between the ADAM12 expression level and immunomodulators. (E, F) Correlations between ADAM12 expression levels and chemokines.